3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
5
Gastrointestinal
1
Conditions
Stomach Neoplasms
4
Colorectal Neoplasms
3
Rectal Neoplasms
2
Pain, Postoperative
2
Liver Neoplasms
2
Colonic Neoplasms
2
Sleep Deprivation
1
Sigmoid Neoplasms
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Lung Injury
1
Kidney Neoplasms
1
Inflammation
1
Hidrocystoma
1
Esophageal Neoplasms
1
Esophageal Atresia
1
Delirium
1
Abscess
1
Interventions
pembrolizumab
36
Magnetic Resonance Spectroscopy
23
Gemcitabine
19
Specimen Handling
15
Nivolumab
12
Carboplatin
12
Surveys and Questionnaires
11
Paclitaxel
11
Cetuximab
11
Early Intervention, Educational
10
Bevacizumab
10
Standard of Care
9
Cyclophosphamide
9
Cisplatin
9
Radiosurgery
8
Methods
8
Fluorouracil
8
Docetaxel
8
Blood Specimen Collection
8
Psychiatric Rehabilitation
7
Pemetrexed
7
sargramostim
6
aldesleukin
6
Taxes
6
Injections
6
Fluorodeoxyglucose F18
6
Educational Status
6
Drug Therapy
6
Biopsy
6
Albumin-Bound Paclitaxel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Dexmedetomidine
×
Gastrointestinal
×
Clear all
NCT00839605
2016-10-04
Dex-One-Lung
University of Missouri-Columbia
Completed
25 enrolled